- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05470543
Effect of Nurse-led Supportive Care on Caregiver Burden and Well-being
January 16, 2023 updated by: Pinar Zorba Bahceli, PhD RN, Izmir Bakircay University
Effect of Nurse-led Supportive Care on Caregiver Burden and Well-being Among Primary Caregivers of Women With Breast Cancer: A Pragmatic Parallel Group Randomized Controlled Trial
Breast cancer is the most common type of cancer in women with a high mortality rate in the world.
Women may experience many different physiological and psychological symptoms (such as pain, nausea-vomiting, fatigue, stress, anger, and isolation) during diagnosis and treatment process.
Family members often become caregivers at the time of diagnosis, and treatment of breast cancer patients.
Therefore, family caregivers experience burden and poor health-related quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This a pragmatic, parallel group randomized controlled trial aimed that investigating the effect of nurse-led supportive care on caregiver burden and well-being among primary caregivers of women with breast cancer.
This trial was conducted in the chemotherapy outpatient clinic of training and research hospital located in Turkey.
All primary caregivers were family members.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Izmir, Turkey, 35560
- Izmir Bakircay University Faculty of Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Being the primary caregiver of breast cancer patients
- Literate
- Able to understand and complete the questionnaires
- Willingness to participate in the study
Exclusion Criteria:
- Having communication problems
- Having psychological diseases
- Receiving any supportive care
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nurse-led Supportive Care Group
|
Nurse-led supportive care was given to primary caregivers of women with breast cancer.
Nurse-led supportive care was applied to primary caregivers for eight weeks in the form of face-to-face clinic interviews.
It took an average of 30 minutes to interview with primary caregivers at the clinic.
|
|
No Intervention: Control Group
The control group received only usual care.
They did not receive any intervention during the study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Zarit Burden Interview (ZBI)
Time Frame: Change from baseline Zarit Burden Interview score at 9th weeks.
|
The ZBI is a measure of caregiving burden developed by Zarit et al. (1980).
The Turkish version of this scale has been validated by Inci and Erdem (2018).
It consists of 22 items, and responses are recorded on a five-point Likert scale.
The level of caregiver burden can be ascertained based on the total scale scores, which range from 0 to 88.
Higher scores indicate a higher level of caregiver burden.The Cronbach's α of the Turkish version of this scale was 0.91 in Inci and Erdem (2018) validation study
|
Change from baseline Zarit Burden Interview score at 9th weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caregiver Well-Being Scale
Time Frame: Change from baseline Caregiver Well-Being Scale score at 9th weeks.
|
The scale was developed by Berg-Weber et al. (2000) in order to measure the level of caregivers of patients with chronic diseases to meet their basic needs and activities of living.
The scale is made up of two subscales, namely, basic needs and activities of living, which try to measure the daily activity level of the caregivers.
It consists of 44 items, and responses are recorded on a five-point Likert scale.
Higher scores indicate a higher level of well-being.
The Cronbach's α of the Turkish version of this scale was 0.86 in Demirtepe and Bozo (2009) validation study.
|
Change from baseline Caregiver Well-Being Scale score at 9th weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Pinar Zorba Bahceli, PhD, Izmir Bakircay University Faculty of Health Sciences Izmir, Turkey, 35560
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 18, 2022
Primary Completion (Actual)
December 24, 2022
Study Completion (Actual)
January 13, 2023
Study Registration Dates
First Submitted
July 19, 2022
First Submitted That Met QC Criteria
July 21, 2022
First Posted (Actual)
July 22, 2022
Study Record Updates
Last Update Posted (Actual)
January 18, 2023
Last Update Submitted That Met QC Criteria
January 16, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019/639
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nurse-led Supportive Care
-
The Hong Kong Polytechnic UniversityRecruitingSelf Efficacy | Mobile Application | Symptom Management | Nurse-led Supportive Care | Child With Medical ComplexityHong Kong
-
Ege Miray TopcuCompletedAnxiety | Nurse-led Supportive Care | Nursing InterventionsTurkey (Türkiye)
-
Izmir Bakircay UniversityCompletedNurse-led Supportive CareTurkey
-
Heyam Adnan JabbarNot yet recruitingNurse Scope, Practice | Nurse Training | Nurse Based Care Management | Nurse Led InterventionsIraq
-
Kathmandu University School of Medical SciencesNot yet recruitingQuality of Life | Self Care | Interdialytic Weight Gain | Patients on Hemodialysis | Nurse Led InterventionsNepal
-
Centre Francois BaclesseLigue contre le cancer, FranceActive, not recruitingLong Term Cancer Side Effects | Supportive Care in Cancer | Cancer Survivorship Care Plan | Advanced Nurse Practitioner | Pelvic Gynecological CancerFrance
-
Eastern Mediterranean UniversityEnrolling by invitationWellness | Muscle Dysmorphia | Bigorexia | Nurse-Led Digital EducationTurkey (Türkiye)
-
İBRAHİM NASAtaturk UniversityEnrolling by invitationNurse's Role | Supportive Care | Patient Relations, NurseTurkey
-
Norfolk and Norwich University Hospitals NHS Foundation...Manchester Centre for Genomic Medicine - St. Mary's Hospital University of...Enrolling by invitationPalliative Care | Supportive CareUnited Kingdom
-
Duke UniversityAstraZenecaCompleted
Clinical Trials on Nurse-led supportive care
-
Izmir Bakircay UniversityCompleted
-
Stanford UniversityNational Institute on Aging (NIA)Active, not recruitingDementia | Mild Cognitive Impairment | Primary Palliative CareUnited States
-
Izmir Bakircay UniversityCompletedNurse-led Supportive CareTurkey
-
British Columbia Cancer AgencyCompleted
-
Radboud University Medical CenterCompleted
-
University of Texas Southwestern Medical CenterCompletedMultidisciplinary CommunicationUnited States
-
The Hong Kong Polytechnic UniversityCompletedBreast Neoplasms | Colorectal NeoplasmsChina
-
Kathmandu University School of Medical SciencesUnknownDiabetes Mellitus, Type 2
-
Umeå UniversityActive, not recruiting
-
Summa Health SystemNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Ohio...Completed